Le, T. Y., Dinh, T. L. A., Le, T. T., Nguyen, X. D., & Nguyen, H. A. (2026). FIRST-LINE TREATMENT OUTCOMES OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: SINGLE-CENTER REAL-WORLD DATA FROM VIETNAM, FROM 2020 TO 2026. Journal of Military Pharmaco-medicine, 51(8), 152-161. https://doi.org/10.56535/jmpm.v51i8.2085